Diagnosis of dry eye disease and emerging technologies

Clinical Ophthalmology

Volumn 8, Issue , 2014, Pages 581-590

  Zeev, Maya Salomon Ben ^a   Miller, Darby Douglas ^b,c   Latkany, Robert ^a,b  

^a The Dry Eye Center   (United States)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

^c Laser and Corneal Surgery Associates   (United States)

Author keywords

Cornea; Dry eye; Stain; Tear film

Indexed keywords

ARTIFICIAL TEAR; BIOLOGICAL MARKER; DYE; FLUORESCEIN; KITON GREEN; ROSE BENGAL; UNCLASSIFIED DRUG;

CLINICAL FEATURE; DIAGNOSTIC VALUE; DRY EYE; EYE EXAMINATION; EYELID REFLEX; FLUORESCEIN CLEARANCE TEST; HUMAN; INTERFEROMETER; INTERFEROMETRY; LAGOPHTHALMOS; OCULAR SURFACE THERMOGRAPHER; OCULAR SURFACE THERMOGRAPHY; OPHTHALMOLOGICAL DIAGNOSTIC DEVICE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; QUESTIONNAIRE; REFLECTIVE MENISCOMETRY; RETINA FLUORESCEIN ANGIOGRAPHY; REVIEW; SCHIRMER TEST; SENSITIVITY AND SPECIFICITY; STAINING; TEAR BREAK UP TIME; TEAR FILM NORMALIZATION TEST; TEAR FILM STABILITY ANALYSIS; TEAR FUNCTION INDEX; TEAR OSMOLARITY TEST; TEAR TESTING EQUIPMENT; VISUAL ACUITY;

EID: 84896445800     PISSN: 11775467     EISSN: 11775483     Source Type: Book Series    
DOI: 10.2147/OPTH.S45444     Document Type: Review

References (104)

1. Nichols KK, Nichols JJ, Mitchen GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23(8):762-770.
2. Schirmer O. Studien zur physiologie und pathologie der tranen-absonderung und tranenabfuhr. Graefes Arch Clin Exp Ophthalmol. 1903;56:197-291. German.
3. De Roetth A. Lacrimation in normal eyes. Arch Ophthalmol. 1953;49(2):185-189.
4. Lemp MA. Report of the National Eye Institute/Industry workshop on the Clinical Trials in Dry Eyes. CLAO J. 1995;21(4):221-232.
5. [No authors listed]. Dry Eye Workshop. The definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007;5(2):75-92.
6. Hashemi H, Khabazkhoob M, Kheirkhah A, et al. Prevalence of dry eye syndrome in an adult population. Clin Experiment Ophthalmol. August 8, 2013. [Epub ahead of print].
7. Scuderi G, Contestabile MT, Gagliano C, Iacovello D, Scuderi L, Avitabile T. Effects of phytoestrogen in postmenopausal women with dry eye syndrome: a randomized clinical trial. Can J Ophthalmol. 2012;47(6):489-492.
8. Rocha EM, Mantelli F, Nominato, Bonini S. Hormones and dry eye syndrome: an update on what we do and don't know. Curr Opin Ophthalmol. 2013;24(4):348-355.
9. Wong J, Lan W, Ong LM, Tong L. Non-hormonal systemic medications and dry eye. Ocul Surf. 2011;9(4):212-226.
10. Farris RL. The dry eye: its mechanism and therapy, with evidence that contact lens is a cause. CLAO J. 1986;12(4):234-246.
11. Grus FH, Sabuncuo P, Augustin A, Pfeiffer N. Effect of smoking on tear proteins. Graefes Arch Clin Exp Ophthalmol. 2002;240(11):889-892.
12. Quinto GG, Camacho W, Behrens A. Postrefractive surgery dry eye. Curr Opin Ophthalmol. 2008;19(4):335-341.
13. Moschos MM, Chatziralli IP, Siasou G, Papazisis L. [Visual problems in young adults due to computer use]. Klin Monbl Augenheilkd. 2012;229(4):379-381. German.
14. Abusharha AA, Pearce EI. The effect of low humidity on the human tear film. Cornea. 2013;32(4):429-434.
15. Palmowski AM, Ruprecht KW. The cornea and systemic diseases. Curr Opin Ophthalmol. 1995;6(4):17-20.
16. Shapiro A, Merin S. Schirmer test and break-up time of tear film in normal subjects. Am J Ophthalmol. 1979;88(4):752-757.
17. Jordan A, Baum J. Basic tear flow. Does it exist? Ophthalmology. 1980;87:920-930.
18. Li N, Deng XG, He MF. Comparison of the Schirmer I test with and without topical anesthesia for diagnosing dry eye. Int J Ophthalmol. 2012;5(4):478-481.
19. Serin D, Karsloglu S, Kyan A, Alagoz G. A simple approach to the repeatability of the Schirmer test without anesthesia: eyes open or closed. Cornea. 2007;26(8):903-906.
20. Kashkouli MB, Pakdel F, Amani A, Asefi M, Aghai GH, Falavarjani KG. A modified Schirmer test in dry eye and normal subjects: open versus closed eye and 1-minute versus 5-minutes tests. Cornea. 2010;29(4):384-387.
21. Nichols KK, Mitchell GL, Zadnik K. The repeatability of clinical measurements of dry eye. Cornea. 2004;23(3):272-285.
22. Bitton E, Wittich W. Influence of eye position on the Schirmer tear test. Cont Lens Anterior Eye. December 18, 2013. [Epub ahead of print].
23. Feldman F, Wood MM. Evaluation of the Schirmer tear test. Can J Ophthalmol. 1979;14(4):257-259.
24. Yoon KC, Im SK, Kim HG, You IC. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome. Cornea. 2011;30(9):972-976.
25. Savini G, Barboni P, Zanini M. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol. 2006;142(2):355-356.
26. Feenstra RP, Tseng SC. What is actually stained by rose bengal? Arch Ophthalmol. 1992;110(7):984-993.
27. Schein OD, Tielsch JM, Munõz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly: a population-based perspective. Ophthalmology. 1997;104(9):1395-1401.
28. Khan-Lim D, Berry M. Still confused about rose bengal? Curr Eye Res. 2004;29(4-5):311-317.
29. Kim J, Foulks GN. Evaluation of the effect of lissamine green and rose bengal on human corneal epitheliual cells. Cornea. 1999;18(3):328-332.
30. Machado LM, Castro RS, Fontes BM. Staining patterns in dry eye syndrome: rose bengal versus lissamine green. Cornea. 2009;28(7):732-734.
31. Hamrah P, Alipour F, Jiang S, Sohn JH, Foulks GN. Optimizing evaluation of lissamine green parameters for ocular surface staining. Eye (Lond). 2011;25(11):1429-1434.
32. Berntsen DA, Mitchell GL, Nichols JJ. Reliability of grading lissamine green conjunctival staining. Cornea. 2006;25(6):695-700.
33. Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22(7):640-650.
34. Van Bijsterveld OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol. 1969;82:10-14.
35. Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E. The challenge of dry eye diagnosis. Clin Ophthalmol. 2008;2(1):31-55.
36. Xu KP, Yagi Y, Toda I, Tsubota K. Tear function index: a new measure of dry eye. Arch Ophthalmol. 1995;113(1):84-88.
37. Kaye SB, Sims G, Willoughby C, Field AE, Longman L, Brown MC. Modification of the tear function index and its use in the diagnosis of Sjogren's syndrome. Br J Ophthalmol. 2001;85(2):193-199.
38. Prabhasawat P, Tseng SC. Frequent association of delayed tear clearance in ocular irritation. Br J Ophthalmol. 1998;82(6):666-675.
39. Afonso AA, Monroy D, Stern ME, Feuer WJ, Tseng SC, Pflugfelder SC. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology. 1999;106(4):803-810.
40. Lemp MA. Breakup of the tear film. Int Ophthalmol Clin. 1973;13(1):97-102.
41. Lemp MA, Hamill JR. Factors affecting tear film breakup in normal eyes. Arch Ophthalmol. 1973;89(2):103-105.
42. Norn MS. Desiccation of the precorneal film. I. Cornea wetting-time. Acta Ophthalmol (Copenh). 1969;47(4):865-880.
43. Norn MS. Desiccation of the precorneal film. II. Permanent discontinuity and dellen. Acta Ophthalmol (Copenh). 1969;47(4):881-889.
44. Vanley GT, Leopold IH, Gregg TH. Interpretation of tear film breakup. Arch Ophthalmol. 1977;95(3):445-448.
45. Lin YY, Carrel H, Wang IJ, et al. Effect of tear film break-up on higher order aberrations of the anterior cornea in normal, dry, and post-LASIK eyes. J Refract Surg. 2005;21(5):S525-S529.
46. Tsubota K, Nakamori K. Dry eyes and video display terminals. N Engl J Med. 1993;328(8):584.
47. Rieger G. The importance of the precorneal tear film for the quality of optical imaging. Br J Ophthalmol. 1992;76(3):157-158.
48. Goto E, Yagi Y, Matsumoto Y, et al. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol. 2002;133(2):181-186.
49. Ishida R, Kojima T, Dogru R, et al. The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol. 2005;139(2):253-258.
50. Kaido M, Dogru M, Ishida R, Tsubota K. Concept of functional visual acuity and its application. Cornea. 2007;26(9 Suppl 1):S29-S35.
51. Mainstone JC, Bruce AS, Golding TR. Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res. 1996;15(6):653-661.
52. Guillon JP. Non-invasive Tearscope Plus routine for contact lens fitting. Cont Lens Anterior Eye. 1998;21 Suppl 1:S31-S40.
53. Fodor E, Hagyó K, Resch M, Somodi D, Németh J. Comparison of Tearscope Plus versus slit lamp measurements of the inferior tear meniscus height in normal individuals. Eur J Ophthalmol. 2010;20(5):819-824.
54. Lamberts DW, Foster CS, Perry HD. Schirmer test after topical anesthesia and the tear meniscus height in normal eyes. Arch Ophthalmol. 1979;97(6):1082-1085.
55. Miller WL, Doughty MJ, Narayanan S, et al. A comparison of tear volume (by tear meniscus height and phenol red thread test) and tear fluid osmolality measures in non-lens wearers and in contact lens wearers. Eye Contact Lens. 2004;30(3):132-137.
56. Savini G, Barboni P, Zanini M. Tear meniscus evaluation by optical coherence tomography. Ophthalmic Surg Lasers Imaging. 2006;37(2):112-118.
57. Yokoi N, Bron A, Tiffany J, Brown N, Hsuan J, Fowler C. Reflective meniscometry: a non-invasive method to measure tear meniscus curvature. Br J Ophthalmol. 1999;83(1):92-97.
58. Bandlitz S, Purslow C, Murphy PJ, Pult H. Comparison of a new portable digital meniscometer and optical coherence tomography in tear meniscus radius measurement. Acta Ophthalmol. October 7, 2013.[Epub ahead of print].
59. Bandlitz S, Purslow C, Murphy PJ, Pult H, Bron AJ. A new portable digital meniscometer. Optom Vis Sci. 2014;91(1):e1-e8.
60. Chen F, Shen M, Chen W, et al. Tear meniscus volume in dry eye after punctal occlusion. Invest Ophthalmol Vis Sci. 2010;51(4):1965-1969.
61. Nguyen P, Huang D, Li Y, et al. Correlation between optical coherence tomography-derived assessments of lower tear meniscus parameters and clinical features of dry eye disease. Cornea. 2012;31(6):680-685.
62. Altan-Yaycioglu R, Sizmas S, Canan H, Coban-Karatas M. Optical coherence tomography for measuring the tear film meniscus: correlation with Schirmer test and tear-film breakup time. Curr Eye Res. 2013;38(7):736-742.
63. Werkmeister RM, Alex A, Kaya S, et al. Measurement of tear film thickness using ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2013;54(8):5578-5583.
64. Garcia N, Teson M, Enriquez-de-Salamanca A, et al. Basal values, intra-day and inter-day variations in tear film osmolarity and tear fluorescein clearance. Curr Eye Res. January 8, 2014. [Epub ahead of print].
65. Kojima T, Ishida R, Dogru M, et al. A new noninvasive tear stability analysis system for the assessment of dry eyes. Invest Ophthalmol Vis Sci. 2004;45(5):1369-1374.
66. Goto T, Zheng X, Klyce SD, et al. A new method for tear film stability analysis using videokeratography. Am J Ophthalmol. 2003;135(5):607-612.
67. Montes-Mico R, Caliz A, Alio JL. Wavefront analysis of higher order aberrations in dry eye patients. J Refract Surg. 2004;20(3):243-247.
68. Doane MG. An instrument for in vivo tear film interferometry. Optom Vis Sci. 1989;66(6):383-388.
69. Blackie CA, Solomon JD, Scaffidi RC, Greiner JV, Lemp MA, Korb DR. The relationship between dry eye symptoms and lipid layer thickness. Cornea. 2009;28(7):789-794.
70. Finis D, Pischel N, Schrader S, et al. Evaluation of lipid layer thickness measurement of the tear film as a diagnostic tool for Meibomian gland dysfunction. Cornea. 2013;32(12):1549-1553.
71. Kent C. Dry-eye diagnosis: 21st-century tools. Review of Ophthalmology. October 2013. Available from: http://www.revophth.com/content/t/dry_eye/c/44198/. Accessed March 4, 2014.
72. Gilbard JP, Farris RL, Santamaria J 2nd. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol. 1978;96(4):677-681.
73. Versura P, Campos EC. TearLab osmolarity system for diagnosing dry eye. Expert Rev Mol Diagn. 2013;13(2):119-129.
74. Szalai E, Berta A, Szekanecz Z, Szucs G, Modis L Jr. Evaluation of tear osmolarity in non-Sjogren and Sjogren syndrome dry eye patients with the TearLab system. Cornea. 2012;31(8):867-871.
75. Li M, Du C, Zhu D, Shen M, Cui L, Wang J. Daytime variations of tear osmolarity and tear meniscus volume. Eye Contact Lens. 2012;38(5):282-287.
76. Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47(10):4309-4315.
77. TearLab. Reimbursement Support Center. Available from: http://www.tearlab.com/products/doctors/reim/reimsuptcenter.htm. Accessed March 4, 2014.
78. Tomlinson A, McCann LC, Pearce EI. Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques. Cornea. 2010;29(9):1036-1041.
79. Nilforoushan MR, Latkany RA, Speaker MG. Effect of artificial tears on visual acuity. Am J Ophthalmol. 2005;140(5):830-835.
80. Latkany R, Lock BG, Speaker M. Tear film normalization test: a new diagnostic test for dry eyes. Cornea. 2006;25(10):1153-1157.
81. Versura P, Bavelloni A, Grillini M, Fresina M, Campos EC. Diagnostic performance of a tear protein panel in early dry eye. Mol Vis. 2013;19:1247-1257.
82. Ohashi Y, Ishida R, Kojima T, et al. Abnormal protein profiles in tears with dry eye syndrome. Am J Ophthalmol. 2003;136(2):291-299.
83. Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001;42(10):2283-2292.
84. Tishler M, Yaron I, Geyer O, Shirazi I, Naftaliev E, Yaron M. Elevated tear interleukin-6 levels in patients with Sjögren syndrome. Ophthalmology. 1998;105(12):2327-2329.
85. Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci. 1994;35(9):3493-3504.
86. Sambursky R, Davitt WF 3rd, Latkany R, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol. 2013;131(1):24-28.
87. Huang JF, Zhang Y, Rittenhouse KD, Pickering EH, McDowell MT. Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease. Invest Ophthalmol Vis Sci. 2012;53(8):4556-4564.
88. Fujishima H, Toda I, Shimazaki J, Tsubota K. Allergic conjunctivitis and dry eye. Br J Ophthalmol. 1996;80(11):994-997.
89. Lee SY, Han SJ, Nam SM, et al. Analysis of tear cytokines and clinical correlations in Sjogren syndrome dry eye patients and non-Sjogren syndrome dry eye patients. Am J Ophthalmol. 2013;156(2):247-253.
90. Shen L, Suresh L, Lindemann M, et al. Novel autoantibodies in Sjogren's syndrome. Clin Immunol. 2012;145(3):251-255.
91. Kamao T, Yamaguchi M, Kawasaki S, Mizoue S, Shiraishi A, Ohashi Y. Screening for dry eye with newly developed ocular surface thermographer. Am J Ophthalmol. 2011;151(5):782-791.
92. Moussa S, Eppig T, Pattmoller J, et al. Diurnal and zonal analysis of corneal surface temperature in young healthy adults. Eur J Ophthalmol. 2013;23(5):641-645.
93. Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52(4):2006-2049.
94. Chalmers RL, Begley CG. Dryness symptoms among an unselected clinical population with and without contact lens wear. Cont Lens Anterior Eye. 2006;29(1):25-30.
95. Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T. Psychometric properties and validation of the Standard Patient Evaluation Of Eye Dryness questionnaire. Cornea. 2013;3(9)2:1204-1210.
96. Schiffman RH, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118(5):615-621.
97. Begley CG, Chalmers RL, Abetz L, et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis Sci. 2003;44(11):4753-4761.
98. Mangione CM, Lee PP, Pitts J, Gutierrez P, Berry S, Hays RD; for the NEI-VFQ Field Test Investigators. Psychometric properties of the National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 1998;116(11):1496-1504.
99. Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R; for the Impact of Dry Eye on Everyday Life (IDEEL) Study Group. Health Qual Life Outcomes. 2011;9:111.
100. Grubbs JR Jr, Tolleson-Rinehart S, Huynh K, Davis RM. A review of quality of life measures in dry eye questionnaires. Cornea. 2014;33(2):215-218.
101. Latkany RL, Lock B, Speaker M. Nocturnal lagophthalmos: an overview and classification. Ocul Surf. 2006;4(1):44-53.
102. Cardona G, García C, Serés C, Vilaseca M, Gispets J. Blink rate, blink amplitude, and tear film integrity during dynamic visual display terminal tasks. Curr Eye Res. 2011;36(3):190-197.
103. Himebaugh NL, Begley CG, Bradley A, Wilkinson JA. Blinking and tear break-up during four visual tasks. Optom Vis Sci. 2009;86(2):E106-E114.
104. Vehof J, Kozareva D, Hysi PG, et al. Relationship between dry eye symptoms and pain sensitivity. JAMA Ophthalmol. 2013;131(10):1304-1308.